Skyrocketing growth in PBM formulary exclusions continues to raise ...

In 2020, Xcenda evaluated the formulary exclusion lists of CVS Caremark,. Express Scripts, and OptumRx and found that the PBMs' standard formularies excluded ...

Each year, pharmacy benefit managers (PBMs) issue lists of drugs they will exclude from coverage in the coming year.

The Big Three PBMs' 2024 Formulary Exclusions: Biosimilar Humira ...

Of this total, 654 (48%) were single-source, brand-name drugs. (See Xcenda's excellent Skyrocketing growth in PBM formulary exclusions continues ...

The Big Three PBMs' Formulary Exclusions Continue to Grow in 2023

Since 2014, the three PBMs have dramatically increased the number of excluded drugs, but the growth rate of exclusions has slowed for the second ...

Latest Formulary Exclusions from Top PBMs Demonstrate Issues in ...

Thus, while employers and plans may use the rebates to lower premiums, those premiums will rise over time since covering higher-priced ...

PBM Formulary Exclusions List Reaches All-Time High - Drug Topics

The number of drugs excluded from the three largest pharmacy benefit manager (PBM) formularies reached an all-time high in 2023.

The Big Three PBMs' 2023 Formulary Exclusions - Drug Channels

The Big Three PBMs' 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars · 1. Exclusions continue to expand. · 2.

Medicare Part D Plans Greatly Increased Utilization Restrictions On ...

The prevalence of formulary exclusions grew particularly fast: By 2020, plan formularies excluded an average of 44.7 percent of brand-name-only ...

Xcenda on LinkedIn: Skyrocketing growth in PBM formulary ...

The pace of formulary exclusions has continued at an astonishing rate over the past few years. Download our latest white paper below to ...

Pharmacy Benefit Managers: What They Say and What They Do

3 Xcenda, Skyrocketing Growth in PBM Formulary Exclusions Continues to Raise Concerns About Patient Access. May 2022 https://www.xcenda.com/-/media/assets ...

Supreme Court of the United States

the 3 PBMs, a 961% increase from 2014, when 109 medicines were excluded.” Skyrocketing Growth In. PBM Formulary Exclusions Continues To Raise.

testimony of lori m. reilly, esq., chief operating officer

Skyrocketing growth in PBM formulary exclusions continues to raise concerns about patient access. May 2022. https://www.xcenda.com/-/media ...

Drug formulary exclusions rise in 2023 - Becker's Hospital Review

Caremark, Express Scripts and OptumRx — the three largest pharmacy benefit managers in the U.S. — increased the number of drugs excluded from ...

PBM Marketplace Issues and Patient Impacts - Vermont Legislature

Source: Xcenda. “Skyrocketing growth in PBM formulary exclusions continues to raise concerns about patient access.” May 2022. Page 11. 10.

FTC Sues Prescription Drug Middlemen for Artificially Inflating ...

Insulin list prices started rising in 2012 with the PBMs' creation of exclusionary drug formularies, the FTC's complaint alleges. Before 2012, ...

March 4, 2024 - Buddy Carter

With less competition, PBMs can continue raising prices and ... skyrocketing-growth-pbm-formulary-exclusions-concerns-patient-access.

1 June 1, 2023 TK Keen, PBM Subgroup Chair Submitted via ... - NAIC

RE: NAIC PBM Subgroup Draft PBM ... pdf. 26 Xcenda. “Skyrocketing Growth in PBM Formulary Exclusions Continues to Raise Concerns About Patient ...

ANNE E. LOPEZ 7609 Attorney General of Hawaiʻi ERIN N. LAU ...

PBMs Exclude Drugs From Their Formularies to Increase ... 47 Xcenda, Skyrocketing growth in PBM formulary exclusions continues to raise concerns ...

Even as PBMs Face Reckoning, Formulary Exclusions Rise Again in ...

In 2023, the country's three largest PBMs are each excluding around 600 drugs from their standard formularies, according to a recent ...

Oregon Prescription Drug Prices Annual Public Hearing

“Skyrocketing growth in PBM formulary exclusions continues to raise concerns about patient access.” May 24, 2022; Drug Channels, Five ...